nodes	percent_of_prediction	percent_of_DWPC	metapath
Tazarotene—CYP2C8—Arachidonate Epoxygenase / Epoxide Hydrolase—COX8A—malignant glioma	0.0429	0.0474	CbGpPWpGaD
Tazarotene—CYP2C8—Diclofenac Metabolic Pathway—CYP2B6—malignant glioma	0.0406	0.0449	CbGpPWpGaD
Tazarotene—RARG—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2B6—malignant glioma	0.0357	0.0395	CbGpPWpGaD
Tazarotene—CYP2C8—Diclofenac Metabolic Pathway—CYP2C18—malignant glioma	0.0352	0.039	CbGpPWpGaD
Tazarotene—RARB—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2B6—malignant glioma	0.032	0.0354	CbGpPWpGaD
Tazarotene—RARA—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2B6—malignant glioma	0.0307	0.0339	CbGpPWpGaD
Tazarotene—CYP2C8—CYP2E1 reactions—CYP2B6—malignant glioma	0.0181	0.02	CbGpPWpGaD
Tazarotene—RXRB—a6b1 and a6b4 Integrin signaling—YWHAE—malignant glioma	0.0154	0.017	CbGpPWpGaD
Tazarotene—RARG—RXR and RAR heterodimerization with other nuclear receptor—PPARG—malignant glioma	0.0142	0.0157	CbGpPWpGaD
Tazarotene—CYP2C8—Oxidation by Cytochrome P450—POR—malignant glioma	0.0132	0.0146	CbGpPWpGaD
Tazarotene—RARB—RXR and RAR heterodimerization with other nuclear receptor—PPARG—malignant glioma	0.0127	0.014	CbGpPWpGaD
Tazarotene—CYP2C8—Arachidonate Epoxygenase / Epoxide Hydrolase—GSTP1—malignant glioma	0.0126	0.014	CbGpPWpGaD
Tazarotene—RARA—RXR and RAR heterodimerization with other nuclear receptor—PPARG—malignant glioma	0.0122	0.0135	CbGpPWpGaD
Tazarotene—RXRB—RXR and RAR heterodimerization with other nuclear receptor—PPARG—malignant glioma	0.0122	0.0135	CbGpPWpGaD
Tazarotene—RARG—RXR and RAR heterodimerization with other nuclear receptor—BCL2—malignant glioma	0.0117	0.013	CbGpPWpGaD
Tazarotene—RXRB—telencephalon—malignant glioma	0.0115	0.12	CbGeAlD
Tazarotene—RARG—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—malignant glioma	0.0114	0.0126	CbGpPWpGaD
Tazarotene—CYP2C8—Xenobiotics—CYP2B6—malignant glioma	0.0112	0.0124	CbGpPWpGaD
Tazarotene—RARG—retina—malignant glioma	0.0111	0.116	CbGeAlD
Tazarotene—RARB—RXR and RAR heterodimerization with other nuclear receptor—BCL2—malignant glioma	0.0105	0.0116	CbGpPWpGaD
Tazarotene—RARG—Nuclear Receptors—PPARG—malignant glioma	0.0104	0.0116	CbGpPWpGaD
Tazarotene—RARB—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—malignant glioma	0.0102	0.0113	CbGpPWpGaD
Tazarotene—RARA—RXR and RAR heterodimerization with other nuclear receptor—BCL2—malignant glioma	0.0101	0.0111	CbGpPWpGaD
Tazarotene—RXRB—RXR and RAR heterodimerization with other nuclear receptor—BCL2—malignant glioma	0.0101	0.0111	CbGpPWpGaD
Tazarotene—RARA—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—malignant glioma	0.00982	0.0109	CbGpPWpGaD
Tazarotene—CYP2C8—Xenobiotics—CYP2C18—malignant glioma	0.00972	0.0108	CbGpPWpGaD
Tazarotene—RARA—telencephalon—malignant glioma	0.00961	0.1	CbGeAlD
Tazarotene—RARB—Nuclear Receptors—PPARG—malignant glioma	0.00937	0.0104	CbGpPWpGaD
Tazarotene—RARB—Integrated Pancreatic Cancer Pathway—STMN1—malignant glioma	0.00902	0.00998	CbGpPWpGaD
Tazarotene—RXRB—Nuclear Receptors—PPARG—malignant glioma	0.00898	0.00994	CbGpPWpGaD
Tazarotene—RARA—Nuclear Receptors—PPARG—malignant glioma	0.00898	0.00994	CbGpPWpGaD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—STMN1—malignant glioma	0.00865	0.00957	CbGpPWpGaD
Tazarotene—RXRB—a6b1 and a6b4 Integrin signaling—MET—malignant glioma	0.00864	0.00955	CbGpPWpGaD
Tazarotene—RARG—Nuclear Receptor transcription pathway—PPARG—malignant glioma	0.00826	0.00913	CbGpPWpGaD
Tazarotene—RXRB—a6b1 and a6b4 Integrin signaling—EGF—malignant glioma	0.00804	0.00889	CbGpPWpGaD
Tazarotene—RARG—RXR and RAR heterodimerization with other nuclear receptor—TNF—malignant glioma	0.00752	0.00831	CbGpPWpGaD
Tazarotene—RARB—Nuclear Receptor transcription pathway—PPARG—malignant glioma	0.0074	0.00819	CbGpPWpGaD
Tazarotene—RARA—Nuclear Receptor transcription pathway—PPARG—malignant glioma	0.0071	0.00785	CbGpPWpGaD
Tazarotene—RXRB—Nuclear Receptor transcription pathway—PPARG—malignant glioma	0.0071	0.00785	CbGpPWpGaD
Tazarotene—RARB—cerebellum—malignant glioma	0.00696	0.0725	CbGeAlD
Tazarotene—RARB—Integrated Pancreatic Cancer Pathway—PLK1—malignant glioma	0.00684	0.00756	CbGpPWpGaD
Tazarotene—RARB—RXR and RAR heterodimerization with other nuclear receptor—TNF—malignant glioma	0.00674	0.00746	CbGpPWpGaD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—PLK1—malignant glioma	0.00656	0.00725	CbGpPWpGaD
Tazarotene—RXRB—central nervous system—malignant glioma	0.00654	0.0682	CbGeAlD
Tazarotene—RARB—Integrated Pancreatic Cancer Pathway—WT1—malignant glioma	0.00648	0.00717	CbGpPWpGaD
Tazarotene—RARA—RXR and RAR heterodimerization with other nuclear receptor—TNF—malignant glioma	0.00646	0.00715	CbGpPWpGaD
Tazarotene—RXRB—RXR and RAR heterodimerization with other nuclear receptor—TNF—malignant glioma	0.00646	0.00715	CbGpPWpGaD
Tazarotene—RXRB—cerebellum—malignant glioma	0.00639	0.0667	CbGeAlD
Tazarotene—RXRB—a6b1 and a6b4 Integrin signaling—ERBB2—malignant glioma	0.00631	0.00698	CbGpPWpGaD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—WT1—malignant glioma	0.00622	0.00688	CbGpPWpGaD
Tazarotene—RARG—central nervous system—malignant glioma	0.00581	0.0605	CbGeAlD
Tazarotene—RARB—Integrated Pancreatic Cancer Pathway—PML—malignant glioma	0.00578	0.00639	CbGpPWpGaD
Tazarotene—RARG—cerebellum—malignant glioma	0.00568	0.0592	CbGeAlD
Tazarotene—RARB—brain—malignant glioma	0.00565	0.0589	CbGeAlD
Tazarotene—RXRB—Regulation of Androgen receptor activity—MDM2—malignant glioma	0.00562	0.00621	CbGpPWpGaD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—PML—malignant glioma	0.00554	0.00613	CbGpPWpGaD
Tazarotene—RARA—central nervous system—malignant glioma	0.00546	0.0569	CbGeAlD
Tazarotene—RARA—cerebellum—malignant glioma	0.00534	0.0556	CbGeAlD
Tazarotene—RARB—Integrated Pancreatic Cancer Pathway—TOP2A—malignant glioma	0.00529	0.00585	CbGpPWpGaD
Tazarotene—RXRB—brain—malignant glioma	0.00519	0.0541	CbGeAlD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—TOP2A—malignant glioma	0.00507	0.0056	CbGpPWpGaD
Tazarotene—RARG—Retinoic acid receptors-mediated signaling—AKT1—malignant glioma	0.00499	0.00552	CbGpPWpGaD
Tazarotene—RARA—Adipogenesis—NCOR1—malignant glioma	0.00469	0.00518	CbGpPWpGaD
Tazarotene—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP2B6—malignant glioma	0.00466	0.00515	CbGpPWpGaD
Tazarotene—RARG—brain—malignant glioma	0.00461	0.0481	CbGeAlD
Tazarotene—CYP2C8—Oxidation by Cytochrome P450—CYP2B6—malignant glioma	0.00459	0.00508	CbGpPWpGaD
Tazarotene—RARB—Retinoic acid receptors-mediated signaling—AKT1—malignant glioma	0.00448	0.00495	CbGpPWpGaD
Tazarotene—RXRB—a6b1 and a6b4 Integrin signaling—EGFR—malignant glioma	0.00438	0.00484	CbGpPWpGaD
Tazarotene—RARA—brain—malignant glioma	0.00434	0.0452	CbGeAlD
Tazarotene—RXRB—Retinoic acid receptors-mediated signaling—AKT1—malignant glioma	0.00429	0.00475	CbGpPWpGaD
Tazarotene—RARA—Retinoic acid receptors-mediated signaling—AKT1—malignant glioma	0.00429	0.00475	CbGpPWpGaD
Tazarotene—RARB—Integrated Pancreatic Cancer Pathway—NTRK1—malignant glioma	0.00411	0.00455	CbGpPWpGaD
Tazarotene—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP2C18—malignant glioma	0.00404	0.00446	CbGpPWpGaD
Tazarotene—CYP2C8—Oxidation by Cytochrome P450—CYP2C18—malignant glioma	0.00398	0.00441	CbGpPWpGaD
Tazarotene—RARA—Adipogenesis—HIF1A—malignant glioma	0.00395	0.00437	CbGpPWpGaD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—NTRK1—malignant glioma	0.00394	0.00436	CbGpPWpGaD
Tazarotene—RARB—Integrated Pancreatic Cancer Pathway—BRCA2—malignant glioma	0.00382	0.00423	CbGpPWpGaD
Tazarotene—RXRB—a6b1 and a6b4 Integrin signaling—PIK3CA—malignant glioma	0.0038	0.0042	CbGpPWpGaD
Tazarotene—RARB—Integrated Pancreatic Cancer Pathway—CDKN2B—malignant glioma	0.00379	0.00419	CbGpPWpGaD
Tazarotene—CYP2C8—Phase 1 - Functionalization of compounds—CYP2B6—malignant glioma	0.00377	0.00417	CbGpPWpGaD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—BRCA2—malignant glioma	0.00366	0.00405	CbGpPWpGaD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—CDKN2B—malignant glioma	0.00363	0.00402	CbGpPWpGaD
Tazarotene—CYP2C8—Arachidonic acid metabolism—PTGS1—malignant glioma	0.00354	0.00391	CbGpPWpGaD
Tazarotene—RARB—Integrated Pancreatic Cancer Pathway—PDGFRA—malignant glioma	0.00344	0.00381	CbGpPWpGaD
Tazarotene—RARA—Adipogenesis—PPARG—malignant glioma	0.00336	0.00371	CbGpPWpGaD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—PDGFRA—malignant glioma	0.0033	0.00365	CbGpPWpGaD
Tazarotene—CYP2C8—Phase 1 - Functionalization of compounds—CYP2C18—malignant glioma	0.00327	0.00362	CbGpPWpGaD
Tazarotene—RXRB—a6b1 and a6b4 Integrin signaling—AKT1—malignant glioma	0.0031	0.00343	CbGpPWpGaD
Tazarotene—RARB—Integrated Pancreatic Cancer Pathway—FGFR1—malignant glioma	0.00307	0.0034	CbGpPWpGaD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—FGFR1—malignant glioma	0.00295	0.00326	CbGpPWpGaD
Tazarotene—RARB—Integrated Pancreatic Cancer Pathway—BAD—malignant glioma	0.00275	0.00305	CbGpPWpGaD
Tazarotene—RARG—Generic Transcription Pathway—NOTCH3—malignant glioma	0.00272	0.00301	CbGpPWpGaD
Tazarotene—RARB—Integrated Pancreatic Cancer Pathway—APC—malignant glioma	0.00267	0.00295	CbGpPWpGaD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—BAD—malignant glioma	0.00264	0.00292	CbGpPWpGaD
Tazarotene—RARB—Integrated Pancreatic Cancer Pathway—EGF—malignant glioma	0.00264	0.00292	CbGpPWpGaD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—APC—malignant glioma	0.00256	0.00283	CbGpPWpGaD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—EGF—malignant glioma	0.00253	0.0028	CbGpPWpGaD
Tazarotene—CYP2C8—Phase 1 - Functionalization of compounds—PTGS1—malignant glioma	0.00248	0.00274	CbGpPWpGaD
Tazarotene—RARB—Generic Transcription Pathway—NOTCH3—malignant glioma	0.00244	0.0027	CbGpPWpGaD
Tazarotene—RARG—Generic Transcription Pathway—NOTCH2—malignant glioma	0.00244	0.0027	CbGpPWpGaD
Tazarotene—RXRB—Generic Transcription Pathway—NOTCH3—malignant glioma	0.00234	0.00259	CbGpPWpGaD
Tazarotene—RARA—Generic Transcription Pathway—NOTCH3—malignant glioma	0.00234	0.00259	CbGpPWpGaD
Tazarotene—RARB—Integrated Pancreatic Cancer Pathway—FGF2—malignant glioma	0.00225	0.00248	CbGpPWpGaD
Tazarotene—RARB—Generic Transcription Pathway—NOTCH2—malignant glioma	0.00219	0.00242	CbGpPWpGaD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—FGF2—malignant glioma	0.00215	0.00238	CbGpPWpGaD
Tazarotene—RARB—Integrated Pancreatic Cancer Pathway—BCL2—malignant glioma	0.00213	0.00236	CbGpPWpGaD
Tazarotene—RARB—Integrated Pancreatic Cancer Pathway—MDM2—malignant glioma	0.0021	0.00232	CbGpPWpGaD
Tazarotene—RXRB—Generic Transcription Pathway—NOTCH2—malignant glioma	0.0021	0.00232	CbGpPWpGaD
Tazarotene—RARA—Generic Transcription Pathway—NOTCH2—malignant glioma	0.0021	0.00232	CbGpPWpGaD
Tazarotene—RARG—Generic Transcription Pathway—CDKN2B—malignant glioma	0.0021	0.00232	CbGpPWpGaD
Tazarotene—RARB—Integrated Pancreatic Cancer Pathway—RAF1—malignant glioma	0.00209	0.00232	CbGpPWpGaD
Tazarotene—RARB—Integrated Pancreatic Cancer Pathway—ERBB2—malignant glioma	0.00207	0.00229	CbGpPWpGaD
Tazarotene—RARA—Adipogenesis—STAT3—malignant glioma	0.00206	0.00228	CbGpPWpGaD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—BCL2—malignant glioma	0.00204	0.00226	CbGpPWpGaD
Tazarotene—RARB—Integrated Pancreatic Cancer Pathway—PTGS2—malignant glioma	0.00203	0.00224	CbGpPWpGaD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—MDM2—malignant glioma	0.00201	0.00223	CbGpPWpGaD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—RAF1—malignant glioma	0.00201	0.00222	CbGpPWpGaD
Tazarotene—CYP2C8—Biological oxidations—CYP2B6—malignant glioma	0.002	0.00222	CbGpPWpGaD
Tazarotene—RARG—Generic Transcription Pathway—NCOR1—malignant glioma	0.00199	0.0022	CbGpPWpGaD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—ERBB2—malignant glioma	0.00199	0.0022	CbGpPWpGaD
Tazarotene—CYP2C8—Metapathway biotransformation—CYP2B6—malignant glioma	0.00198	0.00219	CbGpPWpGaD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—PTGS2—malignant glioma	0.00194	0.00215	CbGpPWpGaD
Tazarotene—RARB—Generic Transcription Pathway—CDKN2B—malignant glioma	0.00188	0.00208	CbGpPWpGaD
Tazarotene—RARB—Integrated Pancreatic Cancer Pathway—CASP3—malignant glioma	0.00188	0.00208	CbGpPWpGaD
Tazarotene—RARG—Gene Expression—DNMT3B—malignant glioma	0.00186	0.00206	CbGpPWpGaD
Tazarotene—RARG—Gene Expression—HIST1H3B—malignant glioma	0.00181	0.002	CbGpPWpGaD
Tazarotene—RXRB—Generic Transcription Pathway—CDKN2B—malignant glioma	0.0018	0.002	CbGpPWpGaD
Tazarotene—RARA—Generic Transcription Pathway—CDKN2B—malignant glioma	0.0018	0.002	CbGpPWpGaD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—CASP3—malignant glioma	0.0018	0.00199	CbGpPWpGaD
Tazarotene—RARB—Generic Transcription Pathway—NCOR1—malignant glioma	0.00178	0.00197	CbGpPWpGaD
Tazarotene—RARA—Adipogenesis—TNF—malignant glioma	0.00178	0.00197	CbGpPWpGaD
Tazarotene—RARB—Integrated Pancreatic Cancer Pathway—PTEN—malignant glioma	0.00177	0.00195	CbGpPWpGaD
Tazarotene—CYP2C8—Biological oxidations—CYP2C18—malignant glioma	0.00174	0.00192	CbGpPWpGaD
Tazarotene—CYP2C8—brain—malignant glioma	0.00172	0.0179	CbGeAlD
Tazarotene—CYP2C8—Metapathway biotransformation—CYP2C18—malignant glioma	0.00171	0.0019	CbGpPWpGaD
Tazarotene—RARA—Generic Transcription Pathway—NCOR1—malignant glioma	0.00171	0.00189	CbGpPWpGaD
Tazarotene—RXRB—Generic Transcription Pathway—NCOR1—malignant glioma	0.00171	0.00189	CbGpPWpGaD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—PTEN—malignant glioma	0.00169	0.00187	CbGpPWpGaD
Tazarotene—RARB—Gene Expression—DNMT3B—malignant glioma	0.00167	0.00184	CbGpPWpGaD
Tazarotene—RARB—Gene Expression—HIST1H3B—malignant glioma	0.00162	0.00179	CbGpPWpGaD
Tazarotene—RXRB—Gene Expression—DNMT3B—malignant glioma	0.0016	0.00177	CbGpPWpGaD
Tazarotene—RARA—Gene Expression—DNMT3B—malignant glioma	0.0016	0.00177	CbGpPWpGaD
Tazarotene—RARB—Integrated Pancreatic Cancer Pathway—VEGFA—malignant glioma	0.0016	0.00176	CbGpPWpGaD
Tazarotene—RXRB—Gene Expression—HIST1H3B—malignant glioma	0.00155	0.00172	CbGpPWpGaD
Tazarotene—RARA—Gene Expression—HIST1H3B—malignant glioma	0.00155	0.00172	CbGpPWpGaD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—VEGFA—malignant glioma	0.00153	0.00169	CbGpPWpGaD
Tazarotene—RARG—Generic Transcription Pathway—NOTCH1—malignant glioma	0.00151	0.00167	CbGpPWpGaD
Tazarotene—RARB—Integrated Pancreatic Cancer Pathway—MYC—malignant glioma	0.00147	0.00162	CbGpPWpGaD
Tazarotene—RARB—Integrated Pancreatic Cancer Pathway—EGFR—malignant glioma	0.00144	0.00159	CbGpPWpGaD
Tazarotene—RARG—Generic Transcription Pathway—PPARG—malignant glioma	0.00143	0.00158	CbGpPWpGaD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—MYC—malignant glioma	0.00141	0.00156	CbGpPWpGaD
Tazarotene—CYP2C8—Biological oxidations—GSTT1—malignant glioma	0.00141	0.00155	CbGpPWpGaD
Tazarotene—RARG—Gene Expression—H3F3A—malignant glioma	0.0014	0.00154	CbGpPWpGaD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—EGFR—malignant glioma	0.00138	0.00152	CbGpPWpGaD
Tazarotene—RARB—Integrated Pancreatic Cancer Pathway—TNF—malignant glioma	0.00137	0.00151	CbGpPWpGaD
Tazarotene—CYP2C8—Arachidonic acid metabolism—PTGS2—malignant glioma	0.00136	0.0015	CbGpPWpGaD
Tazarotene—RARB—Integrated Pancreatic Cancer Pathway—KRAS—malignant glioma	0.00136	0.0015	CbGpPWpGaD
Tazarotene—RARB—Generic Transcription Pathway—NOTCH1—malignant glioma	0.00136	0.0015	CbGpPWpGaD
Tazarotene—CYP2C8—Biological oxidations—PTGS1—malignant glioma	0.00132	0.00146	CbGpPWpGaD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—TNF—malignant glioma	0.00131	0.00145	CbGpPWpGaD
Tazarotene—RARG—Gene Expression—NOTCH3—malignant glioma	0.00131	0.00145	CbGpPWpGaD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—KRAS—malignant glioma	0.0013	0.00144	CbGpPWpGaD
Tazarotene—RXRB—Generic Transcription Pathway—NOTCH1—malignant glioma	0.0013	0.00144	CbGpPWpGaD
Tazarotene—RARA—Generic Transcription Pathway—NOTCH1—malignant glioma	0.0013	0.00144	CbGpPWpGaD
Tazarotene—RARB—Generic Transcription Pathway—PPARG—malignant glioma	0.00128	0.00141	CbGpPWpGaD
Tazarotene—RARB—Gene Expression—H3F3A—malignant glioma	0.00125	0.00138	CbGpPWpGaD
Tazarotene—RARB—Integrated Pancreatic Cancer Pathway—PIK3CA—malignant glioma	0.00125	0.00138	CbGpPWpGaD
Tazarotene—RARA—Generic Transcription Pathway—PPARG—malignant glioma	0.00123	0.00136	CbGpPWpGaD
Tazarotene—RXRB—Generic Transcription Pathway—PPARG—malignant glioma	0.00123	0.00136	CbGpPWpGaD
Tazarotene—RARB—Integrated Pancreatic Cancer Pathway—TP53—malignant glioma	0.00121	0.00133	CbGpPWpGaD
Tazarotene—RXRB—Gene Expression—H3F3A—malignant glioma	0.0012	0.00133	CbGpPWpGaD
Tazarotene—RARA—Gene Expression—H3F3A—malignant glioma	0.0012	0.00133	CbGpPWpGaD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—PIK3CA—malignant glioma	0.00119	0.00132	CbGpPWpGaD
Tazarotene—RARB—Gene Expression—NOTCH3—malignant glioma	0.00118	0.0013	CbGpPWpGaD
Tazarotene—RARG—Gene Expression—NOTCH2—malignant glioma	0.00118	0.0013	CbGpPWpGaD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—TP53—malignant glioma	0.00116	0.00128	CbGpPWpGaD
Tazarotene—RARA—Gene Expression—NOTCH3—malignant glioma	0.00113	0.00125	CbGpPWpGaD
Tazarotene—RXRB—Gene Expression—NOTCH3—malignant glioma	0.00113	0.00125	CbGpPWpGaD
Tazarotene—RARB—Gene Expression—NOTCH2—malignant glioma	0.00105	0.00117	CbGpPWpGaD
Tazarotene—RARB—Integrated Pancreatic Cancer Pathway—AKT1—malignant glioma	0.00102	0.00113	CbGpPWpGaD
Tazarotene—RARA—Gene Expression—NOTCH2—malignant glioma	0.00101	0.00112	CbGpPWpGaD
Tazarotene—RXRB—Gene Expression—NOTCH2—malignant glioma	0.00101	0.00112	CbGpPWpGaD
Tazarotene—RARG—Gene Expression—CDKN2B—malignant glioma	0.00101	0.00112	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—RTEL1—malignant glioma	0.000985	0.00109	CbGpPWpGaD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—AKT1—malignant glioma	0.000976	0.00108	CbGpPWpGaD
Tazarotene—CYP2C8—Biological oxidations—GSTP1—malignant glioma	0.000974	0.00108	CbGpPWpGaD
Tazarotene—CYP2C8—Metapathway biotransformation—GSTP1—malignant glioma	0.000961	0.00106	CbGpPWpGaD
Tazarotene—RARG—Gene Expression—NCOR1—malignant glioma	0.000958	0.00106	CbGpPWpGaD
Tazarotene—RARB—Gene Expression—CDKN2B—malignant glioma	0.000906	0.001	CbGpPWpGaD
Tazarotene—RARA—Gene Expression—CDKN2B—malignant glioma	0.000868	0.000961	CbGpPWpGaD
Tazarotene—RXRB—Gene Expression—CDKN2B—malignant glioma	0.000868	0.000961	CbGpPWpGaD
Tazarotene—RARB—Gene Expression—NCOR1—malignant glioma	0.000859	0.00095	CbGpPWpGaD
Tazarotene—RARA—Gene Expression—NCOR1—malignant glioma	0.000824	0.000911	CbGpPWpGaD
Tazarotene—RXRB—Gene Expression—NCOR1—malignant glioma	0.000824	0.000911	CbGpPWpGaD
Tazarotene—RARG—Generic Transcription Pathway—MYC—malignant glioma	0.000813	0.000899	CbGpPWpGaD
Tazarotene—RARB—Generic Transcription Pathway—MYC—malignant glioma	0.000729	0.000807	CbGpPWpGaD
Tazarotene—RARG—Gene Expression—NOTCH1—malignant glioma	0.000727	0.000805	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism of lipids and lipoproteins—IDH1—malignant glioma	0.000704	0.000779	CbGpPWpGaD
Tazarotene—RARA—Generic Transcription Pathway—MYC—malignant glioma	0.000699	0.000773	CbGpPWpGaD
Tazarotene—RXRB—Generic Transcription Pathway—MYC—malignant glioma	0.000699	0.000773	CbGpPWpGaD
Tazarotene—RARG—Gene Expression—PPARG—malignant glioma	0.000687	0.000759	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism of lipids and lipoproteins—SPHK1—malignant glioma	0.000681	0.000754	CbGpPWpGaD
Tazarotene—RARB—Gene Expression—NOTCH1—malignant glioma	0.000652	0.000722	CbGpPWpGaD
Tazarotene—RXRB—Gene Expression—NOTCH1—malignant glioma	0.000625	0.000692	CbGpPWpGaD
Tazarotene—RARA—Gene Expression—NOTCH1—malignant glioma	0.000625	0.000692	CbGpPWpGaD
Tazarotene—RARB—Gene Expression—PPARG—malignant glioma	0.000616	0.000681	CbGpPWpGaD
Tazarotene—RXRB—Gene Expression—PPARG—malignant glioma	0.00059	0.000653	CbGpPWpGaD
Tazarotene—RARA—Gene Expression—PPARG—malignant glioma	0.00059	0.000653	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—COX8A—malignant glioma	0.000566	0.000626	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism of lipids and lipoproteins—PTGS1—malignant glioma	0.000506	0.00056	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—ASMT—malignant glioma	0.000481	0.000532	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism of lipids and lipoproteins—BCHE—malignant glioma	0.00047	0.00052	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—BCAN—malignant glioma	0.000452	0.0005	CbGpPWpGaD
Tazarotene—RARG—Gene Expression—MYC—malignant glioma	0.000391	0.000433	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—IDH2—malignant glioma	0.000365	0.000403	CbGpPWpGaD
Tazarotene—RARB—Gene Expression—MYC—malignant glioma	0.000351	0.000388	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	0.000344	0.00038	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—CYP2B6—malignant glioma	0.000343	0.000379	CbGpPWpGaD
Tazarotene—RXRB—Gene Expression—MYC—malignant glioma	0.000337	0.000372	CbGpPWpGaD
Tazarotene—RARA—Gene Expression—MYC—malignant glioma	0.000337	0.000372	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—IDH1—malignant glioma	0.000314	0.000347	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—SPHK1—malignant glioma	0.000303	0.000336	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—CYP2C18—malignant glioma	0.000297	0.000329	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	0.00028	0.00031	CbGpPWpGaD
Tazarotene—RARG—Gene Expression—AKT1—malignant glioma	0.000271	0.0003	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	0.000255	0.000282	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	0.000246	0.000273	CbGpPWpGaD
Tazarotene—RARB—Gene Expression—AKT1—malignant glioma	0.000243	0.000269	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—GSTT1—malignant glioma	0.00024	0.000266	CbGpPWpGaD
Tazarotene—RARA—Gene Expression—AKT1—malignant glioma	0.000233	0.000258	CbGpPWpGaD
Tazarotene—RXRB—Gene Expression—AKT1—malignant glioma	0.000233	0.000258	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—PTGS1—malignant glioma	0.000225	0.000249	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	0.000224	0.000248	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—BCHE—malignant glioma	0.000209	0.000232	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—SLC5A5—malignant glioma	0.000207	0.000229	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	0.000196	0.000216	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	0.000194	0.000214	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	0.000169	0.000187	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—GSTP1—malignant glioma	0.000167	0.000184	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—CAT—malignant glioma	0.000162	0.000179	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—NCOR1—malignant glioma	0.000153	0.000169	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—CAV1—malignant glioma	0.000125	0.000138	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	0.000119	0.000132	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—PIK3CG—malignant glioma	0.000114	0.000126	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—PPARG—malignant glioma	0.00011	0.000121	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—PIK3CD—malignant glioma	0.0001	0.000111	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—PIK3CB—malignant glioma	8.71e-05	9.64e-05	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—PTGS2—malignant glioma	8.63e-05	9.55e-05	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—PTEN—malignant glioma	7.53e-05	8.33e-05	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—PIK3CA—malignant glioma	5.31e-05	5.87e-05	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—AKT1—malignant glioma	4.34e-05	4.8e-05	CbGpPWpGaD
